Charles River News

Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278

MT NewswiresApr 12 10:20 ET

Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating

MT NewswiresMar 22 11:38 ET

Charles River Analyst Ratings

BenzingaMar 18 10:10 ET

Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating

MT NewswiresFeb 16 07:50 ET

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Charles River Labs (CRL) and Shockwave Medical (SWAV)

TipRanksFeb 16 07:20 ET

Evercore ISI Remains a Buy on Charles River Labs (CRL)

TipRanksFeb 15 19:25 ET

Baird Adjusts Price Target on Charles River Laboratories International to $268 From $252, Maintains Outperform Rating

MT NewswiresFeb 15 10:23 ET

Charles River Analyst Ratings

BenzingaFeb 15 08:01 ET

Charles River Labs: A Cautious Hold Amidst Anticipated Second-Half Recovery

TipRanksFeb 15 06:18 ET

Charles River Analyst Ratings

BenzingaDec 20, 2023 14:55 ET

UBS Adjusts Charles River Laboratories International Price Target to $270 From $215, Maintains Buy Rating

MT NewswiresDec 15, 2023 10:57 ET

Charles River Analyst Ratings

BenzingaDec 11, 2023 07:02 ET

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), HCA Healthcare (HCA) and Becton Dickinson (BDX)

TipRanksNov 10, 2023 23:20 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Charles River Labs (CRL) and Stryker (SYK)

TipRanksNov 10, 2023 04:20 ET

Charles River Labs (CRL) Gets a Hold From TD Cowen

TipRanksNov 9, 2023 17:18 ET

UBS Maintains Buy on Charles River, Lowers Price Target to $215

BenzingaNov 9, 2023 14:50 ET

Charles River Analyst Ratings

BenzingaNov 9, 2023 14:48 ET

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $215 From $236, Maintains Buy Rating

MT NewswiresNov 9, 2023 11:36 ET

Hold Rating on Charles River Labs Amid DSA Stabilization and Forecasted Modest Growth

TipRanksNov 8, 2023 21:55 ET

Morgan Stanley Maintains Equal-Weight on Charles River, Lowers Price Target to $220

BenzingaOct 24, 2023 08:23 ET